Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas US Names Medical Affairs SVP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Astellas US Names Medical Affairs SVP

Bloss to serve as a member of the management committee

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jeffrey D. Bloss, M.D., has been promoted to senior vice president, Medical Affairs Americas, Astellas Scientific and Medical Affairs (ASMA). Dr. Bloss will serve as a member of the Astellas US Management Committee.

Dr. Bloss joined the company in October 2012, and has been responsible for leading the America’s Regional Medical Affairs function. He also had direct oversight of the Medical Affairs functions in Canada and Brazil, establishing strong collaborations with other functions throughout the company to optimize medical/scientific value across the product lifecycle. 
 
Prior to joining the company, he was vice president and head of Oncology Global Medical Affairs at GlaxoSmithKline, and he served in various leadership roles at Eli Lilly and Co., Genentech and Onyx Pharmaceuticals.

“Jeff has been a key partner and thought leader to the Global Medical Affairs function since joining Astellas in 2012,” said Masao Yoshida, chief executive officer, Astellas US LLC. “We’re thrilled to promote Jeff to his new role as SVP of Medical Affairs for the Americas for ASMA.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters